Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART)

International Journal of Radiation Oncology, Biology, Physics, Volume 97, Issue 4, 2017 Mar 15 | Ringash, Jolie, MD; Fisher, Richard, PhD; Peters, Lester, MD;...
Summary Among 861 overall participants in a negative phase 3 randomized trial of concurrent chemoradiation therapy with or without the hypoxic cell cytotoxic agent tirapazamine, a subset of 200 had oropharyngeal cancer, known p16 status, and quali...

http://ift.tt/2lBdPHe

http://ift.tt/2mtBXt0